Comparison of the effects of intramyocardial and intravenous injections of human mesenchymal stem cells on cardiac regeneration after heart failure

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 330

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-23-7_007

تاریخ نمایه سازی: 27 مرداد 1399

چکیده مقاله:

Objective(s): Existing studies have demonstrated that intravenous and intramyocardial-administrated mesenchymal stem cells (MSCs) lead to tissue repair after cardiac disorders. We compared the efficiency of both administration methods.Materials and Methods: A rat model of isoproterenol-induced heart failure (ISO-HF) was established to compare the effects of intravenous and intramyocardial-administrated MSCs on cardiac fibrosis and function. The animals were randomly assigned into six groups: i) control or normal, ii) ISO-HF (HF) iii) ISO-HF rats treated with intramyocardial administration of culture medium (HF+IM/CM), iv) ISO-HF rats treated with intravenous administration of culture medium ( HF+IV/CM), v) ISO-HF rats treated with intravenous administration of MSCs (HF+IV/MSCs), vi) ISO-HF rats treated with intramyocardial administration of MSCs ( HF+IM/MSCs). Cultured MSCs and culture medium were administrated at 4 weeks after final injection of ISO. Heart function, identification of MSCs, osteogenic differentiation, adipogenic differentiation, cardiac fibrosis and tissue damage were evaluated by echocardiography, flow-cytometery, von Kossa, oil red O, Masson’s trichrome and H & E staining, respectively. Results: Both intravenous and intramyocardial MSCs therapy significantly improved heart function and reduced cardiac fibrosis and tissue damage (P<0.05), whereas the cultured medium had no beneficial effects. Conclusion: In sum, our results confirm the validity of both administration methods in recovery of HF, but more future research is required.

نویسندگان

Behnaz Mokhtari

Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran|Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

Nahid Aboutaleb

Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran|Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

Donya Nazarinia

Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran|Department of Physiology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran

Mahin Nikougoftar

Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Pfau D, Thorn SL, Zhang J, Mikush N, Renaud JM, ...
  • Amani H, Habibey R, Hajmiresmail S, Latifi S, Pazoki-Toroudi H, ...
  • Saporito F, Baugh LM, Rossi S, Bonferoni MC, Perotti C, ...
  • Li L, Zhang S, Zhang Y, Yu B, Xu Y, ...
  • Zhang W, Zhang J, Kang Y, Liu J, Wang X, ...
  • Chia N, Fulcher J, Keech A. Beta‐blocker, angiotensin‐converting enzyme inhibitor/angiotensin ...
  • Li L, Zhang Y, Li Y, Yu B, Xu Y, ...
  • Amani H, Mostafavi E, Arzaghi H, Davaran S, Akbarzadeh A, ...
  • Sun S-q, Wang X-t, Qu X-f, Li Y, Yu Y, ...
  • Arabian M, Aboutaleb N, Soleimani M, Mehrjerdi FZ, Ajami M, ...
  • Pazoki-Toroudi H, Nassiri-Kashani M, Tabatabaie H, Ajami M, Habibey R, ...
  • Kumar M, Kasala ER, Bodduluru LN, Dahiya V, Lahkar M. ...
  • Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells-current ...
  • Amani H, Arzaghi H, Bayandori M, Dezfuli AS, Pazoki‐Toroudi H, ...
  • Premer C, Blum A, Bellio MA, Schulman IH, Hurwitz BE, ...
  • Tousi SMTR, Faghihi M, Nobakht M, Molazem M, Kalantari E, ...
  • Malliaras K, Li T-S, Luthringer D, Terrovitis J, Cheng K, ...
  • Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms ...
  • Li Y, Zhang Y, Li Z, Zhou K, Feng N. ...
  • Nazarinia D, Aboutaleb N, Gholamzadeh R, Maleki SN, Mokhtari B, ...
  • Amirfarhangi A, Dezfouli M, Abarkar M, Rakhshan K, Aboutaleb N. ...
  • Lee S-T, White AJ, Matsushita S, Malliaras K, Steenbergen C, ...
  • Amado LC, Saliaris AP, Schuleri KH, John MS, Xie J-S, ...
  • Luger D, Lipinski MJ, Westman PC, Glover DK, Frias JC, ...
  • Faezi M, Maleki SN, Aboutaleb N, Nikougoftar M. The membrane ...
  • Aboutaleb N, Faezi M, Maleki SN, Nazarinia D, Tousi SMTR, ...
  • Nasseri Maleki S, Aboutaleb N, Nazarinia D, Allahverdi Beik S, ...
  • Meeran MFN, Jagadeesh GS, Selvaraj P. Catecholamine toxicity triggers myocardial ...
  • Tousi SMTR, Amirizadeh N, Nasirinezhad F, Nikougoftar M, Ganjibakhsh M, ...
  • Li X, Yu X, Lin Q, Deng C, Shan Z, ...
  • Li W, Gan R, Sun G. Chronic treatment of enbrel ...
  • Rodriguez AJ, Mousa A, Ebeling PR, Scott D, De Courten ...
  • Amani H, Mostafavi E, Alebouyeh MR, Arzaghi H, Akbarzadeh A, ...
  • Amani H, Habibey R, Shokri F, Hajmiresmail SJ, Akhavan O, ...
  • Amani H, Kazerooni H, Hassanpoor H, Akbarzadeh A, Pazoki-Toroudi H. ...
  • Javedan G, Shidfar F, Davoodi SH, Ajami M, Gorjipour F, ...
  • Firooz A, Bouzari N, Mojtahed F, Pazoki-Toroudi H, Nassiri-Kashani M, ...
  • Booth EA, Lucchesi BR. Estrogen-mediated protection in myocardial ischemia-reperfusion injury. ...
  • Cheng G, Labedz-Maslowska A, Berdecka D, Xuan Y-T, Samanta A, ...
  • Jiang Q, Yu T, Huang K, Zhang H, Zheng Z, ...
  • Wang W, Jin P, Wang L, Yang Z, Hu S, ...
  • Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, ...
  • Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, ...
  • Lim M, Wang W, Liang L, Han Z-b, Li Z, ...
  • نمایش کامل مراجع